Microarrays may be hot now, but in a few years, analysts say the market for these and other biochips will really begin to sizzle.
Qiagen subsidiary Operon said it has discontinued sales of its pre-fabricated, medium-density OpArrays in North America, due to concerns that they might infringe on Affymetrix s patent portfolio.
What does the microarray world look like from the summit of the mountain?
This is a sample story for bio array news and mcirochips and arrays of all natures. If you want to go further we can go into all kinds of screwwy details about the following: ChipsDipsSpreadsSauces.You name it.
This is some content
In the wake of the announcement that the working draft of the human genome sequence is done, BioInform spoke with four informatics
The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.
There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.
The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.
In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.